OtherArticle
Antitumor Mechanisms of Systemically Administered Epidermal Growth Factor Receptor Antisense Oligonucleotides in Combination with Docetaxel in Squamous Cell Carcinoma of the Head and Neck
Sufi Mary Thomas, Michelene Jeter Ogagan, Maria L Frelino, Sandra Strychors, Dustin R Walsh, William E Gooding, Jennifer Rubin Grandis and William C Zamboni
Molecular Pharmacology November 19, 2007, DOI: https://doi.org/10.1124/mol.107.041160
Sufi Mary Thomas
Michelene Jeter Ogagan
Maria L Frelino
Sandra Strychors
Dustin R Walsh
William E Gooding
Jennifer Rubin Grandis
Jump to comment:
No eLetters have been published for this article.
In this issue
Molecular Pharmacology
Vol. 105, Issue 4
1 Apr 2024
OtherArticle
Antitumor Mechanisms of Systemically Administered Epidermal Growth Factor Receptor Antisense Oligonucleotides in Combination with Docetaxel in Squamous Cell Carcinoma of the Head and Neck
Sufi Mary Thomas, Michelene Jeter Ogagan, Maria L Frelino, Sandra Strychors, Dustin R Walsh, William E Gooding, Jennifer Rubin Grandis and William C Zamboni
Molecular Pharmacology November 19, 2007, DOI: https://doi.org/10.1124/mol.107.041160
OtherArticle
Antitumor Mechanisms of Systemically Administered Epidermal Growth Factor Receptor Antisense Oligonucleotides in Combination with Docetaxel in Squamous Cell Carcinoma of the Head and Neck
Sufi Mary Thomas, Michelene Jeter Ogagan, Maria L Frelino, Sandra Strychors, Dustin R Walsh, William E Gooding, Jennifer Rubin Grandis and William C Zamboni
Molecular Pharmacology November 19, 2007, DOI: https://doi.org/10.1124/mol.107.041160
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement